CTRI/2012/03/002492已完成未知
A prospective, comparative study to evaluate the glycemic index of test (food)products: Rice 1, Rice 2, Rice 3 and Rice 4 in controlled type 2 diabetic patients. - Nil
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- Marico Ltd
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients diagnosed to be suffering from Type 2 diabetes mellitus taking oral hypoglycemic drugs or insulin and with blood sugar stabilized within normal range(Fasting sugar level < 110 mg/dl &
- •Postprandial sugar level < 140 mg/dl )
- •2. Patients of either sex in the age group between 30 to 60 years.
- •3. Patients confirmed to be in normal health status by performing the below mentioned investigations
- •A) clinical examination B) Haematological investigations: Hemoglobin, Complete blood count & Erythrocyte sedimentation rate C) Biochemical investigations: Alanine transaminase, aspartate
- •transaminase, serum proteins, Albumin globulin ratio, serum bilirubin,fasting blood glucose, postprandial blood glucose level, blood urea
- •nitrogen and serum creatinine D) X-ray chest E) Electrocardiogram
- •F)Urine pregnancy test for female patients G) HIV 1, 2 & HBsAg testing
- •All the above mentioned investigations must be normal (parameters tested in all investigations must be in the normal range ± 5% as reflected in the reports)
- •4. Patient with body mass index of >18.5kg/m 2 and < 25 kg/m2 [1]
- •5. Patient with HbA1C < 7%
- •6. Subjects who provide a written informed consent to abide by the study requirements.
排除标准
- •1. Patients diagnosed as Type 1 diabetes mellitus 2.Presence of any clinically significant abnormal results of investigations done at screening e.g. significant abnormality of Liver Function Test
- •(more than 2.5 times upper limit of normal), & Renal Function Test (more than 1.5 times upper limit of normal),fasting glucose >110 mg% , postprandial blood sugar level > 140 mg%
- •3.Patients in the last one month with
- •A) any major illness requiring hospitalization
- •B) acute exacerbation of any ongoing chronic medical illness e.g.Congestive cardiac failure, Hepatitis, Hypotensive episodes, etc. Medications requiring change of doses for treatment of the
- •chronic illness
- •2. Patients suffering from severe cardiac, renal, liver or any other organ impairment.
- •3. History of seizures, epilepsy or anyneurological disorders.
- •4. Consumption of alcohol / tobacco products within 48 hours prior to dosing of test /reference product and during the study period (17 days to 33 days )
- •5. Use of any recreational drug or a history of drug addiction.
- •6. Participation in any clinical trial within the past 90 days.
- •7. Receipt of any other prescription drug or over the counter (OTC) drugs for more than 24 hours within two weeks prior to receiving the first dose of test or food product
- •8. An unusual diet, special diet, e.g. high protein diet, low sodium diet, for two weeks prior to receiving any test food product and
- •throughout subjectâ??s participation in the study.
- •9. Recent history of dehydration from diarrhoea, vomiting or any other reason within a period of 24 hours prior to the study.
- •10. Patient with any history of food allergy
- •11. Pregnant or lactating females
研究者
相似试验
撤回
不适用
A prospective study to investigate the impact of glucose variability using continuous glucose monitoring system on heart function in patients with type 2 diabetes.KCT0005475The Catholic University of Korea, St. Vincent's Hospital50
尚未招募
2 期
A clinical trial to study the effects of two drugs, gudardraka nasal drops and shadbindu oil nasal drops in patients with sinusitis.CTRI/2020/04/024671Dr Nijil A V
招募中
Unknown
Prospective comparative study about influence on gut microbiome by medication of fexuprazan and esomeprazoleDiseases of the digestive systemKCT0008702Ajou University Hospital60
尚未招募
不适用
An observational study on patients with non-segmental vitiligo patients on NB-UVB and to look for effect on progression of the disease.CTRI/2016/04/006809All India Institute of Medical Sciences30
尚未招募
Unknown
A study to compare the genetic profile of early and advanced stages of gallbladder adenocarcinoma cases who have not taken any chemotherapy and/or radiotherapyCTRI/2023/08/056775Mahamana Pandit Madan Mohan Malaviya cancer Centre